An assessment of dicyclomine hydrochloride ('Merbentyl') in the irritable colon syndrome.
D002986:Clinical Trials as Topic; D003109:Colonic Diseases, Functional / Q000188:drug therapy*; D005769:Gastrointestinal Motility / Q000187:drug effects; D006801:Humans; D010276:Parasympatholytics / Q000009:adverse effects / Q000627:therapeutic use*; D010634:Phenobarbital / Q000627:therapeutic use; D010919:Placebos
D010276:Parasympatholytics; D010919:Placebos; D010634:Phenobarbital